NCT01086254 - SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

119

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Non-small Cell Lung Cancer Stage IV

Interventions

DRUG

Iniparib

"Pharmaceutical form: solution for infusion~Route of administration: 60-minute IV infusion"

DRUG

gemcitabine

"Pharmaceutical form: solution for infusion~Route of administration: 30-minute IV infusion"

DRUG

cisplatin

"Pharmaceutical form: solution for infusion~Route of administration: 1- to 4-hour IV infusion, according to the local standard"

Trial Locations (14)

10043

Sanofi-Aventis Investigational Site Number 380001, Orbassano

13009

Sanofi-Aventis Investigational Site Number 250003, Marseille

14033

Sanofi-Aventis Investigational Site Number 250002, Caen

20089

Sanofi-Aventis Investigational Site Number 380002, Rozzano

22927

Sanofi-Aventis Investigational Site Number 276001, Großhansdorf

31059

Sanofi-Aventis Investigational Site Number 250004, Toulouse

45122

Sanofi-Aventis Investigational Site Number 276003, Essen

57123

Sanofi-Aventis Investigational Site Number 380003, Livorno

82131

Sanofi-Aventis Investigational Site Number 276002, Gauting

94805

Sanofi-Aventis Investigational Site Number 250001, Villejuif

08916

Sanofi-Aventis Investigational Site Number 724001, Badalona

08035

Sanofi-Aventis Investigational Site Number 724002, Barcelona

NE7 7DN

Sanofi-Aventis Investigational Site Number 826001, Newcastle upon Tyne

WV10 0QP

Sanofi-Aventis Investigational Site Number 826002, Wolverhampton